Levine_Norman-2.jpg
Norman Levine, M.D.
Norman Levine, M.D., is a private practitioner in Tucson, Ariz. He also is a member of the Dermatology Times Editorial Advisory board and a co-medical editor.
The future of dermatology
Until recently, dermatology was an almost universally well-respected medical and surgical discipline. The scope of the specialty appears to be narrowing. If we relinquish the authority to manage skin disorders to concentrate on more lucrative pursuits such as selling products, we will cease to be relevant and our patients will suffer.
PODCAST: Advances in psoriasis treatment
The past few years have been an exciting time for those who treat psoriasis and for many patients with severe disease because of excellent new therapies for this often intractable problem. Norman Levine, M.D., talks with Alan Menter, M.D., Baylor University Medical Center, Dallas, about recent developments in the treatment of psoriasis.
Does gluten drive skin disease?
Does gluten drive skin disease?
Gluten and gluten-sensitive enteropathy have become hot topics among the lay public and in medical practices. John Zone, M.D., from the University of Utah, Salt Lake City, discusses how gluten sensitive enteropathy may impact many areas of dermatology.
PODCAST: A plethora of aesthetic products
Cosmetic concerns are important to many of our patients. Among the difficulties faced by consumers is the blitz of advertising of new and presumably revolutionary products that can rejuvenate and preserve the youthful appearance of the skin. Many products make what sound like medical claims about the efficacy of these agents. Norman Levine, M.D., asked Zoe Draelos, M.D., the foremost authority on this subject, to discuss these issues with us.
A clinician’s opinion on ineffective dermatologic therapies
Over the decades, many highly useful treatment modalities have been developed which have greatly improved the lives of our patients. However, many additional therapies with questionable usefulness have also become part of our treatment armamentarium.
PODCAST: A changing landscape
The landscape of dermatology is rapidly changing and every practicing dermatolo-gist will almost certainly be affected. Dermatology Times asked Dirk Elston, M.D., president of the American Academy of Dermatology, to address some of these issues so that we may all have a better idea of what lies ahead for our specialty.
Why do dermatologists resist hospital consults?
Dermatologists have become extremely reluctant to participate in hospital activities such as evaluating in-patients as consultants, serving on hospital committees, and participating in educational activities in the hospital. the most troubling is our resistance to see patients at the hospital bedside. There are a number of apparently legitimate excuses for the failure of dermatologists to visit the hospital wards.
Seeing is believing, but real benefits arise when the physician is the patient
For the first time in my life, I had the experience of being on the other side of the doctor-patient relationship. I would not recommend it to anyone, but I learned a lot of valuable lessons about medical care, some of which have direct relevance to the way we all should be practicing medicine.
Today's published research must be scrutinized for validity, accuracy
In my early years in dermatology, there were many distinguished and acknowledged experts whose published findings became part of the core of the discipline. When they presented their findings at medical meetings or in print, one assumed that the data was valid and accurate, and it was often translated into specific management options for our patients.
A peek into tomorrow's insurance, medical paradigms isn't pretty
A few months ago, I received a certified letter from one of the Medicare Advantage insurance carriers with which we are contracted. The letter stated that our services were no longer needed. They had no complaints about the services we were delivering; rather, they had made the decision to hire a nurse practitioner to care for the dermatologic needs of their enrollees.

Poll

View Results